Tyra Biosciences, Inc. TYRA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s financing cash flow?
- Tyra Biosciences, Inc. (TYRA) reported financing cash flow of $160.38M in Q1 2026.
- How has Tyra Biosciences, Inc.'s financing cash flow changed year-over-year?
- Tyra Biosciences, Inc.'s financing cash flow increased by 7233.5% year-over-year, from $2.19M to $160.38M.
- What is the long-term trend for Tyra Biosciences, Inc.'s financing cash flow?
- Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s financing cash flow has grown at a 134.0% compound annual growth rate (CAGR), from $632K to $8.1M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.